Business Context and Reporting Period
Company: Disc Medicine, Inc. (Nasdaq: IRON)
Filing Type: Form 8-K (Current Report)
Date of Report: May 5, 2026
Reporting Period: First Quarter ended March 31, 2026
Context: The filing announces financial results for Q1 2026 and provides a corporate update. The detailed financial data is contained in a press release furnished as Exhibit 99.1, which is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The filing states that revenue, profit, cash flow, margins, debt, and liquidity figures are detailed in the attached press release (Exhibit 99.1). Consequently, no specific values for these metrics can be extracted from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Outlook: The company provided a corporate update alongside the financial results, but specific guidance or forward-looking statements are not included in the text of this Form 8-K.
Risks and Contingencies: No specific risks or contingencies are detailed in this summary document. The filing includes standard disclaimers regarding the status of the furnished information.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q1 2026 revenue, net loss, and cash burn rates.
- Verify the specific details of the "corporate update" mentioned in Item 2.02, as this may contain strategic shifts or clinical trial updates.
- Confirm the company's cash runway and liquidity position as of March 31, 2026, which is not stated in this cover sheet.
- Check for any new debt instruments or equity issuances referenced in the full press release.